153 related articles for article (PubMed ID: 38231269)
1. Novel biomarkers and neuroimaging techniques in Parkinson's disease.
Saw A; Bari S; Robertson NP
J Neurol; 2024 Feb; 271(2):1056-1058. PubMed ID: 38231269
[No Abstract] [Full Text] [Related]
2. Imaging in Parkinson's Disease.
Politis M; Pagano G; Niccolini F
Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging in pre-motor Parkinson's disease.
Barber TR; Klein JC; Mackay CE; Hu MTM
Neuroimage Clin; 2017; 15():215-227. PubMed ID: 28529878
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging advances in Parkinson's disease.
Rispoli V; Schreglmann SR; Bhatia KP
Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
[TBL] [Abstract][Full Text] [Related]
5. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis.
Conrado DJ; Nicholas T; Tsai K; Macha S; Sinha V; Stone J; Corrigan B; Bani M; Muglia P; Watson IA; Kern VD; Sheveleva E; Marek K; Stephenson DT; Romero K;
Clin Transl Sci; 2018 Jan; 11(1):63-70. PubMed ID: 28749580
[TBL] [Abstract][Full Text] [Related]
6. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
[TBL] [Abstract][Full Text] [Related]
7. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?
Hanganu A; Monchi O
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):91. PubMed ID: 30324260
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review.
Otani RTV; Yamamoto JYS; Nunes DM; Haddad MS; Parmera JB
Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):116-125. PubMed ID: 35976320
[TBL] [Abstract][Full Text] [Related]
9. Sex effects on brain structure in de novo Parkinson's disease: a multimodal neuroimaging study.
Tremblay C; Abbasi N; Zeighami Y; Yau Y; Dadar M; Rahayel S; Dagher A
Brain; 2020 Oct; 143(10):3052-3066. PubMed ID: 32980872
[TBL] [Abstract][Full Text] [Related]
10. Update on Molecular Imaging in Parkinson's Disease.
Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J
Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614
[TBL] [Abstract][Full Text] [Related]
11. Multi-View Graph Convolutional Network and Its Applications on Neuroimage Analysis for Parkinson's Disease.
Zhang X; He L; Chen K; Luo Y; Zhou J; Wang F
AMIA Annu Symp Proc; 2018; 2018():1147-1156. PubMed ID: 30815157
[TBL] [Abstract][Full Text] [Related]
12. What would Dr. James Parkinson think today? II. Neuroimaging in Parkinson's disease.
Albin RL
Mov Disord; 2017 Feb; 32(2):179-180. PubMed ID: 28218459
[No Abstract] [Full Text] [Related]
13. Joint-Connectivity-Based Sparse Canonical Correlation Analysis of Imaging Genetics for Detecting Biomarkers of Parkinson's Disease.
Kim M; Won JH; Youn J; Park H
IEEE Trans Med Imaging; 2020 Jan; 39(1):23-34. PubMed ID: 31144631
[TBL] [Abstract][Full Text] [Related]
14. Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.
Broderick PA; Wenning L; Li YS
J Neural Transm (Vienna); 2017 Jan; 124(1):57-78. PubMed ID: 27796511
[TBL] [Abstract][Full Text] [Related]
15. Structural MRI in Idiopathic Parkinson's Disease.
De Micco R; Russo A; Tessitore A
Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.
Yang J; Burciu RG; Vaillancourt DE
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):83. PubMed ID: 30280267
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection.
Frosini D; Cosottini M; Volterrani D; Ceravolo R
Curr Opin Neurol; 2017 Aug; 30(4):416-426. PubMed ID: 28537985
[TBL] [Abstract][Full Text] [Related]
18. Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
Dean DC; Sojkova J; Hurley S; Kecskemeti S; Okonkwo O; Bendlin BB; Theisen F; Johnson SC; Alexander AL; Gallagher CL
PLoS One; 2016; 11(10):e0163774. PubMed ID: 27706215
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.
Shinde S; Prasad S; Saboo Y; Kaushick R; Saini J; Pal PK; Ingalhalikar M
Neuroimage Clin; 2019; 22():101748. PubMed ID: 30870733
[TBL] [Abstract][Full Text] [Related]
20. Imaging genetics approach to Parkinson's disease and its correlation with clinical score.
Kim M; Kim J; Lee SH; Park H
Sci Rep; 2017 Apr; 7():46700. PubMed ID: 28429747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
